Latest Shareholder Value News

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.

Prodigy Gold NL has announced a non-renounceable entitlement offer aiming to raise approximately $6.35 million to fund exploration and development across its key gold projects in the Tanami region. The offer is partially underwritten, providing a degree of funding certainty amid ongoing market and operational risks.

Caravel Minerals has locked in a $15 million loan facility to fund the critical Definitive Feasibility Study for its flagship Caravel Copper Project, advancing the path to development without diluting shareholder equity.

Meeka Metals reports significant new shallow high-grade oxide gold drill results at Turnberry Central, extending the Stage 1 open pit and promising to boost production beyond initial plans.

Lefroy Exploration has secured its inaugural toll milling agreement for the Lucky Strike Gold Project, marking a significant step towards production with a February 2026 milling slot at Greenfields Mill.

Platinum Capital Limited has taken a significant step towards restructuring by lodging a draft scheme booklet to convert shareholder investments into an active ETF, aiming to resolve its persistent discount to net tangible assets.

Cobalt Blue Holdings has completed a scoping study for its Halls Creek Project in Western Australia, outlining a staged development plan with promising economics and a sustainable power strategy. The project targets near-term copper and zinc production with a modest initial capital outlay.

High-Tech Metals has successfully completed a $2.5 million placement, positioning the company to ramp up its exploration activities with fresh capital and strategic options incentives.

Dateline Resources has upgraded its U.S. trading status to OTCQB, enhancing liquidity and investor access as interest surges around its Colosseum Gold-REE Project in California.

Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.

Tivan Limited has extended Executive Chairman Grant Wilson’s term by three years, accompanied by a salary increase and proposed performance rights designed to align his incentives with shareholder value as the company advances its Speewah Fluorite Project.